Stocks and Investing Stocks and Investing
Tue, January 14, 2014
Mon, January 13, 2014
Fri, January 10, 2014
Thu, January 9, 2014
Wed, January 8, 2014

Christopher Marai Initiated (BIIB) at Strong Buy and Held Target at $368 on, Jan 8th, 2014


Published on 2024-10-25 03:59:56 - WOPRAI, Christopher Marai
  Print publication without navigation


Christopher Marai of Nomura, Initiated "Biogen Inc." (BIIB) at Strong Buy and Held Target at $368 on, Jan 8th, 2014.

Christopher has made no other calls on BIIB in the last 4 months.



There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Christopher


  • Christopher Raymond of "Piper Sandler" Initiated at Buy on, Tuesday, November 26th, 2013
  • Evan Seigerman of "Credit Suisse" Maintained at Buy and Held Target at $290 on, Friday, November 22nd, 2013
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $340 on, Friday, November 22nd, 2013
Contributing Sources